Stocks › LIFE
Ethos Technologies LIFE
US equityMarket cap rank #2671
$31.22 −$0.91 (-2.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.29 +3.43%
Open$31.73
Prev close$32.13
Day range$30.93 – $33.10
Volume1.46M
Market cap$2.03B
P/E (TTM)–
Dividend yield–
LIFE Stock News
Headlines matching Ethos Technologies or the LIFE ticker, most recent first.
- Aoyama Trading: Statutory Post-Disclosure Documents (Corporate Split) (Custom Life Co., Ltd.)
- Stifel Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $18
- CHieru: Seven companies of the Chier Group have joined the Ministry of Health, Labour and Welfare's "Smart Life Project."
- Maxim Group Maintains Sellas Life Sciences(SLS.US) With Buy Rating, Maintains Target Price $30
- Life Time(LTH.US) Director Sells US$78.9 Million in Common Stock
- Breakeven Is Near for Suja Life, Inc. (NASDAQ:SUJA)
- Daiichi Life Group: Supplementary Materials for the Second Quarter Financial Results for the Fiscal Year Ending March 2027 (First Frontier Life Insurance Co., Ltd. Segment)
- Daiichi Life Group: Supplementary Materials for the Six Months Ended September 30, 2026 (Daiichi Neo Life Insurance Co., Ltd.)
- Daiichi Life Group: Supplementary Materials for the Six Months Ended September 30, 2026 (Daiichi Frontier Life Insurance Co., Ltd.)
- Daiichi Life Group: Daiichi Life Group, Inc. Outline Materials for the Three Months Ended September 30, 2026
- Daiichi Life Group: First Life Group Co., Ltd. – Summary of Second Quarter Financial Results for the Fiscal Year Ending March 2027
- Daiichi Life Group: Supplementary Materials for the Second Quarter Financial Results for the Fiscal Year Ending March 2027 (First Neo Life Insurance Co., Ltd. Segment)
- KeyBanc Maintains Life Time(LTH.US) With Buy Rating, Maintains Target Price $55
- Citi Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $15 Negative
- A Quick Look at Today's Ratings for Suja Life(SUJA.US), With a Forecast Between $5 to $17
No comments yet — be the first to weigh in on LIFE.
Sign in to join the discussion.